Literature DB >> 25329489

Different 6-Aryl-Fulvenes Exert Anti-proliferative effects on Cancer Cells.

Esther Sirignano, Assunta Pisano, Anna Caruso, Carmela Saturnino, Maria Stefania Sinicropi1, Rosamaria Lappano, Antonio Botta, Domenico Iacopetta, Marcello Maggiolini, Pasquale Longo.   

Abstract

Fulvenes represent a class of molecules very interesting under a chemical point of view because are easily accessible starting materials and are still poorly characterized for their biological activities, with the exception of acylfulvene and irofulvenes which have been reported to exert cytotoxic properties. Here, we describe the synthesis and characterization of several aryl-fulvenes together with their effects on cancer cell growth by MTT method. The cytotoxic potential was investigated on a panel of tumor cell lines such as breast MCF7 and SkBr3, endometrial Ishikawa, prostate LnCaP and lung A549, in comparison with the cis-diamminedichloroplatinum(II) (cisplatin) which is largely used for the treatment of different types of cancer. The evaluation of the cytotoxic activity of these compounds indicated that they are able to inhibit the proliferation of the aforementioned cancer cell types. In particular, the compound 4 exhibited the most powerful antiproliferative activity on all tumor cells evaluated with higher inhibitory effects respect to cisplatin and without altering the proliferation of human mammary MCF-10A epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25329489     DOI: 10.2174/1871520614666141019190855

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  1 in total

1.  Synthesis and Antitumor Activity of New Group 3 Metallocene Complexes.

Authors:  Angelamaria Caporale; Giuseppe Palma; Annaluisa Mariconda; Vitale Del Vecchio; Domenico Iacopetta; Ortensia Ilaria Parisi; Maria Stefania Sinicropi; Francesco Puoci; Claudio Arra; Pasquale Longo; Carmela Saturnino
Journal:  Molecules       Date:  2017-03-28       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.